MENU

GENB

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Generate Biomedicines (GENB) Ownership - Who owns Generate Biomedicines?

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

1.88B

P/E Ratio

N/A

Total Cash

516.64M

Projected Growth

N/A

Total Debt

65.57M

Revenue

30.3M

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash/Share

4.03

Total Debt/Equity

N/A

Revenue/Share

0.24 USD as % of share price

View a ticker or compare two or three

VS

VS

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for GENB

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Details